Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Albion International was a global leader in the manufacture of superior organic mineral compounds, with over 100 patents, leveraging scientific expertise in human and plant nutrition. Its products were known for high bioavailability and technological advancement in mineral delivery. The company was acquired by Balchem Corporation in 2015, which continues to market Albion's mineral chelate products globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Albion International.